Clinical trials sponsored by St Vincent's Hospital, Sydney

Phase breakdown

Conditions studied

Recruiting trials led by St Vincent's Hospital, Sydney

• Adding IL-2 to Tebentafusp to Eradicate Cancer Progression
  NCT07063875 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Bipolar Androgen Therapy + Carboplatin in mCRPC
  NCT03522064 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Stage 1
  NCT07552922 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer
  NCT04947189 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Tebentafusp and Roginolisib in Uveal Melanoma to Prolong T-cell Homeostasis
  NCT07203391 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Common questions

How many trials is St Vincent's Hospital, Sydney recruiting for?

St Vincent's Hospital, Sydney is the lead sponsor of 5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.